Your browser doesn't support javascript.
loading
Targeting Bcl-2/Bcl-XL induces antitumor activity in uveal melanoma patient-derived xenografts.
Némati, Fariba; de Montrion, Catherine; Lang, Guillaume; Kraus-Berthier, Laurence; Carita, Guillaume; Sastre-Garau, Xavier; Berniard, Aurélie; Vallerand, David; Geneste, Olivier; de Plater, Ludmilla; Pierré, Alain; Lockhart, Brian; Desjardins, Laurence; Piperno-Neumann, Sophie; Depil, Stéphane; Decaudin, Didier.
Afiliação
  • Némati F; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, Paris, France.
  • de Montrion C; I.D.R.S., Institut de Recherches Servier, Croissy, France.
  • Lang G; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, Paris, France.
  • Kraus-Berthier L; I.R.I.S., Institut de Recherches International Servier, Suresnes, France.
  • Carita G; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, Paris, France.
  • Sastre-Garau X; Department of Tumor Biology, Institut Curie, Paris, France.
  • Berniard A; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, Paris, France.
  • Vallerand D; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, Paris, France.
  • Geneste O; I.R.I.S., Institut de Recherches International Servier, Suresnes, France.
  • de Plater L; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, Paris, France.
  • Pierré A; I.D.R.S., Institut de Recherches Servier, Croissy, France.
  • Lockhart B; I.D.R.S., Institut de Recherches Servier, Croissy, France.
  • Desjardins L; Department of Ophthalmological Oncology, Institut Curie, Paris, France.
  • Piperno-Neumann S; Department of Medical Oncology, Institut Curie, Paris, France.
  • Depil S; I.D.R.S., Institut de Recherches Servier, Croissy, France ; I.R.I.S., Institut de Recherches International Servier, Suresnes, France.
  • Decaudin D; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, Paris, France ; Department of Medical Oncology, Institut Curie, Paris, France.
PLoS One ; 9(1): e80836, 2014.
Article em En | MEDLINE | ID: mdl-24454684
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Prevencao_e_fatores_de_risco / Agentes_cancerigenos / Tipos_de_cancer / Pele Base de dados: MEDLINE Assunto principal: Sulfonamidas / Neoplasias Uveais / Ensaios Antitumorais Modelo de Xenoenxerto / Proteína bcl-X / Terapia de Alvo Molecular / Compostos Heterocíclicos com 3 Anéis / Melanoma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Prevencao_e_fatores_de_risco / Agentes_cancerigenos / Tipos_de_cancer / Pele Base de dados: MEDLINE Assunto principal: Sulfonamidas / Neoplasias Uveais / Ensaios Antitumorais Modelo de Xenoenxerto / Proteína bcl-X / Terapia de Alvo Molecular / Compostos Heterocíclicos com 3 Anéis / Melanoma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: França